Warning that pharmaceutical giant could face risks on two fronts

Drugs pricing issues highlighted
Pharmaeceutical giant Astrazeneca could be at risk on two fronts, it was claimed today, after the Anglo-Swedish group announced its annual results for 2019.Pre-tax profits fell by 22% to $1.548bn, although total sales jumped by 10% to $24.384bn.Astrazeneca employs around 4,700 people in the North West on sites at Macclesfield and Alderley Park in Cheshire and Speke on Merseyside.Unveiling the figures today, chief executive Pascal Soriot said today: "In the first full year of our return to growth, we made good progress in l... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...